HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Volume 20, No. 8, August 2016 – Novel Technologies for Antibody Drug Discovery in Japan       » Global Experts Convene to Discuss China's Plan for Diabetes Prevention and Rehabilitation in 2016       » Butterflies Offer Climate Scientists Ecological Insights       » Thermal Stability of Camelid Single Domain VHH Antibody       » That Gut Feeling: How A Healthy Digestive System Has Everything To Do With It       » World Heart Day - At the Heart of Health      
EYE on CHINA
ScinoPharm Changshu teams up with Sundia MediTech
ScinoPharm (Changshu) Pharmaceuticals and Sundia MediTech Company Ltd. has announced a strategic alliance to seek more opportunities for collaboration in Contract Research and Manufacturing Services (CRAMS) in mainland China and to tap into this large and growing business potential.

The cooperation will combine Sundia's diversified technical know-how and capabilities in new drug R&D with ScinoPharm's process R&D and commercial production advantages, especially in the field of highly potent oncological APIs.

"Resources from our Changshu site in Jiangsu province, China, and the Shanghai-based CRO company Sundia will be combined to establish a robust collaboration with single-source solutions to address the increasing number of multinational companies shifting their drug development research and clinical trials in China," reported Dr. Jo Shen, CEO of ScinoPharm Taiwan and chairman of ScinoPharm Changshu.

"Sundia has established long-standing and strong relationships with a number of big pharmaceuticals and small/ medium-sized biotech companies from the US, Europe, Japan and South Korea in the fields of chemistry, biology, preclinical, formulation and API manufacture, helping our clients and partners to bring drugs to the market efficiently," said Dr. Chen Chen, Sundia's CEO." Sundia is very pleased to have the opportunity to work with ScinoPharm, a world-leading process R&D and API manufacturing service provider. I am sure that the strategic partnership between Sundia and ScinoPharm will have mutual benefits, helping each other to thrive in both international and China Market."

Founded by a group of veterans from the US biopharmaceutical industry in 2004, Sundia MediTech Company Ltd. is a Shanghai-based Clinical Research Organization (CRO) providing drug discovery and development services worldwide with a research team of over 600 employees. Currently, Sundia has successfully established collaborations with over 100 clients in North America, Europe, and Japan, according to the company.

Founded in 2009, ScinoPharm Changshu is located at Changshu Economic Development Zone in Jiangsu Province. ScinoPharm Changshu is a subsidiary of ScinoPharm Taiwan Ltd., which is a process R&D and API manufacturing service provider to the global pharmaceutical industry. With research and manufacturing facilities in both Taiwan and China, ScinoPharm offers services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry. The company also provides a vertically integrated, one-stop-shopping service for its API customers by expanding into the field of oncological injectable formulations.

Click here for the complete issue.

NEWS CRUNCH  
news CPhI's Pre-Connect Congress outlines current trends in pharma
news World Population Day 2016
news NUS Student Clinches Top Prize at National Smart Mapping Competition with Cutting-Edge Food Security Solution
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2016
January:
Guest Editorial - Biotechnology In Korea
February:
Guest Editorial - Biomedical Research Governance
March:
Guest Editorial - Life-Saving Opportunities: A Guide to Regenerative Medicine
April:
Leading-Edge ONCOLOGY
May:
Healthcare Systems & Policies in Asia
June:
Medical Devices & Healthcare Technology
July:
Water Technology and Management
August:
Novel Technologies for Antibody Drug Discovery in Japan
September:
Infectious Diseases
October:
Medical Tourism
November:
Big Data in Healthcare
December:
Evidence-based TCM
Editorial calendar is subjected to changes.
– Editor: Carmen, Jia Wen Loh
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com or Mr Edward
Copyright© 2016 World Scientific Publishing Co Pte Ltd  •  Privacy Policy